Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial

Published:2024-09 Issue: Volume:164 Page:209438
ISSN:2949-8759
Container-title:Journal of Substance Use and Addiction Treatment
language:en
Short-container-title:Journal of Substance Use and Addiction Treatment

Author:

Balter Dylan Rose,Puglisi Lisa B.,Dziura James,Fiellin David A.,Howell Benjamin A.

Funder

National Institutes of Health

National Institute on Alcohol Abuse and Alcoholism

NIDA

Publisher

Elsevier BV

Reference47 articles.

1. Revisiting the X:BOT naltrexone clinical trial using a comprehensive survival analysis;Ajazi;Journal of Addiction Medicine,2022

2. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff;Andraka-Christou;The American Journal of Drug and Alcohol Abuse,2020

3. Court personnel attitudes towards medication-assisted treatment: A state-wide survey;Andraka-Christou;Journal of Substance Abuse Treatment,2019

4. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants;Barocas;Drug and Alcohol Dependence,2015

5. Mortality after prison release: Opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009;Binswanger;Annals of Internal Medicine,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP